Drug giants GlaxoSmithKline and Novartis have conceded part of the ACCC’s case that packaging on their Voltaren Osteo Gel breached the Australian Consumer Law, but said the label was changed almost a year ago.
Subscribe for instant access to all Lawyerly content.
